A phase II trial of the Src-kinase inhibitor saracatinib after four cycles of chemotherapy for patients with extensive stage small cell lung cancer: NCCTG trial N-0621

查看全文 作　　者：Julian;R.;Molina;Nathan;R.;Foster;Thanyanan;Reungwetwattana;Garth;D.;Nelson;Andrew;V.;Grainger;Preston;D.;Steen;Philip;J.;Stella;Randolph;Marks;John;Wright;Alex;A.;Adjei 出　　处：《Lung Cancer》索引2014年,共0页